ライフサイエンスコーパス: intracardiac

1 echocardiography at 10 min (transesophageal/intracardiac), 24 h, 1 month, and 6 months (transthoraci

2 sted OR, 2.25; 95% CI, 1.25-4.03; P = .007), intracardiac abscess (47/144 [32.6%]; adjusted OR, 1.86;

3 confidence interval, 1.21-3.68; P=0.006) and intracardiac abscess (hazard ratio, 2.25; 95% confidence

4 Intracardiac abscess (hazard ratio, 2.93; 95% confidence

5 In S aureus LNVIE, intracardiac abscess and left ventricular ejection fract

6 endently predicted in-hospital mortality and intracardiac abscess and valve perforation independently

7 on in their plasma levels but an increase in intracardiac accumulation of both cytokines.

8 e combination of paced P wave morphology and intracardiac activation sequence can be used for the ide

9 ing to match the P wave morphology and paced intracardiac activation sequence recorded from multiple

10 G at the successful ablation site, and paced intracardiac activation sequence was identical to that o

11 Intracardiac administration of amniotic fluid stem cells

12 Intracardiac air was detected on TEE less than 30 second

13 n led to the discovery of massive amounts of intracardiac air which demanded urgent lung isolation an

14 d to what extent these Treg subsets regulate intracardiac allogeneic responses in transplant patients

15 rtook analysis of NF-kappaB and IkappaB mRNA intracardiac allograft expression, and NF-kappaB nuclear

16 nsional image using multiple views, evaluate intracardiac anatomy at different depth planes, and recr

17 c burden and extended survival in MDA-MB-231 intracardiac and 4T1 orthotopic (median survival, >80 da

18 d the ability to colonize the bone following intracardiac and direct intratibial injection of athymic

19 gical analysis demonstrated the formation of intracardiac and extracardiac teratomas.

20 Intracardiac and pulmonary artery pressure-guided manage

21 diac shunt may occur in patients with normal intracardiac and pulmonary artery pressures.

22 es the diagnostic tools for the detection of intracardiac and pulmonary shunts, reviews therapeutic o

23 redominant alpha7-nAChR subtype found in rat intracardiac and superior cervical ganglion neurons exhi

24 eaction techniques in neonatal rat brain and intracardiac and superior cervical ganglion neurons.

25 ncludes fluoroscopy, lateral roentgenograms, intracardiac and surface electrocardiograms, and thresho

26 kg) administered at the time of reperfusion (intracardiac) and then daily (intravenous) for the first

27 In contrast, intracardiac ANG II was increased greater than twofold i

28 ial defect, anterior diaphragmatic defect or intracardiac anomalies.

29 ncreased cardiac fibrosis and suppression of intracardiac anti-fibrotic cytokines, while premenopausa

30 The use of intracardiac assist devices is expanding, and correct po

31 The intracardiac bipolar atrial electrogram recordings were

32 study, all of the rats were euthanized, and intracardiac blood samples and mandible tissues were obt

33 At the end of the study, intracardiac blood samples and mandible tissues were obt

34 An intracardiac cardioverter defibrillator was implanted in

35 d weight < or =70 kg, as well as the lack of intracardiac cardioverter-defibrillator on the day of li

36 DMI data were collected using a phased-array intracardiac catheter (LV cavity) from ischemic and noni

37 e ability to localize and accurately display intracardiac catheter positioning and ablation lesion si

38 reased cardiac inflammation, increased total intracardiac CD45(+) leukocytes, elevated anti-cardiac m

39 natriuretic peptide (NT-proBNP(1-76)) after intracardiac cleavage of their molecular precursor, proB

40 g a diagnosis, and in identifying associated intracardiac complications.

41 Recognition of intracardiac constant fusion with this method is a novel

42 to assess the exact roles of circulating and intracardiac cytokines in this particular patient popula

43 omalies of the aortic arch and no associated intracardiac defects for deletions within chromosome 22q

44 ng, including outflow tract, arch artery and intracardiac defects.

45 with 5% tilt is delivered to the heart via 2 intracardiac defibrillation leads.

46 p detects evidence of cardiomyopathy, and an intracardiac defibrillator is implanted to reduce the ri

47 yarrhythmias during follow-up and 3 received intracardiac defibrillator shocks for ventricular tachyc

48 mmunosuppressive therapy, and 56 received an intracardiac defibrillator.

49 ograph images, which can be used to evaluate intracardiac device position.

50 endocarditis include absence of a permanent intracardiac device, sterile follow-up blood cultures wi

51 As the use of intracardiac devices has increased, the awareness of the

52 Infection in the presence of intracardiac devices is a problem of considerable morbid

53 e endocarditis (IE) in prosthetic valves and intracardiac devices is challenging because both the mod

54 pacemaker placement (3 L-loop ventricles, 2 intracardiac devices, 1 double inlet-double outlet RV).

55 rfarin), use (or planned use) of implantable intracardiac devices, and blood pressure control (<140/9

56 ughout institutions that serve patients with intracardiac devices.

57 ensus statement about the ethical removal of intracardiac devices.

58 bout the ethical acceptability of removal of intracardiac devices.

59 Intracardiac ECGs remained stable, while surface ECGs ch

60 Surface and intracardiac ECGs revealed prolongation of the PR, QRS,

61 Intracardiac ECGs, done in three patients, were correlat

62 atheter closure under transesophageal and/or intracardiac echocardiographic guidance.

63 Intracardiac echocardiographic imaging of the heart duri

64 eliminated from the adjacent RA under direct intracardiac echocardiographic visualization.

65 catheter at the ostium of the LAA guided by intracardiac echocardiography (167 patients; group 3).

66 lar implantable electronic device leads with intracardiac echocardiography (ICE) during ablation proc

67 t of left atrial (LA) thrombus documented by intracardiac echocardiography (ICE) during LA ablation f

68 e transesophageal echocardiography (TEE) and intracardiac echocardiography (ICE) for the diagnosis of

69 to determine the feasibility and accuracy of intracardiac echocardiography (ICE) in guiding percutane

70 Intracardiac echocardiography (ICE) is used to assist at

71 ve of this study was to assess the impact of intracardiac echocardiography (ICE) on the long-term suc

72 rial fibrillation (AF), we sought the use of intracardiac echocardiography (ICE) to evaluate PV anato

73 All patients underwent PVAI with an intracardiac echocardiography (ICE)-guided approach with

74 using a multipolar Lasso catheter guided by intracardiac echocardiography (ICE).

75 ossible during the procedure with the use of intracardiac echocardiography (ICE).

76 Baseline intracardiac echocardiography (ICE, 10.5F, Siemens), flu

77 ckness measured by NFUS correlated well with intracardiac echocardiography (r=0.86; P<0.0001).

78 LAA sealing was confirmed by intracardiac echocardiography and contrast fluoroscopy.

79 d the occurrence of bubble formation seen on intracardiac echocardiography and the microembolic signa

80 ps between the degree of bubble formation on intracardiac echocardiography and the number of MESs (P=

81 a sham procedure (femoral venous access with intracardiac echocardiography but no IASD placement).

82 electroanatomic mapping in conjunction with intracardiac echocardiography demonstrated that 1 of the

83 Intracardiac echocardiography detected all potentially a

84 tion of the PSP-LV with an RA approach under intracardiac echocardiography guidance were performed in

85 Intracardiac echocardiography guided device closure of s

86 The development of intracardiac echocardiography has led to real-time guida

87 Intracardiac echocardiography imaging was performed in 2

88 Intracardiac echocardiography improves the outcome of co

89 Intracardiac echocardiography is a novel imaging techniq

90 rve as origins of presumed RVOT arrhythmias; intracardiac echocardiography localization of the PV all

91 Intracardiac echocardiography monitored catheter positio

92 Intracardiac echocardiography successfully guided closur

93 rated in vivo using 3-dimensional integrated intracardiac echocardiography to localize the PV.

94 endocardial site of activation under direct intracardiac echocardiography visualization.

95 ns were confirmed as supravalvular by direct intracardiac echocardiography visualization.

96 Intracardiac echocardiography was used to visualize and

97 tion based on PV angiography, 102; guided by intracardiac echocardiography, 140; with energy delivery

98 ls include transesophageal echocardiography, intracardiac echocardiography, intracardiac endoscopy, a

99 Most of this review will be devoted to intracardiac echocardiography, which currently has the b

100 ping, multidetector computed tomography, and intracardiac echocardiography, with arrhythmia foci bein

101 ntricle) and compared with measurements from intracardiac echocardiography.

102 h computed tomography, 3D imaging (NAVX), or intracardiac echocardiography.

103 ing power to microbubble formation guided by intracardiac echocardiography.

104 and ablation approach from the RA guided by intracardiac echocardiography.

105 to the time of fixation, the duration of the intracardiac EGM in ventricular leads increased from 150

106 Intracardiac electrical stimulation revealed that both m

107 g either the surface electrocardiogram or an intracardiac electrogram (Eg) as the timing reference.

108 ury was characterized as the duration of the intracardiac electrogram (EGM) and the magnitude of ST-s

109 Pacing threshold and intracardiac electrogram amplitude were unchanged over t

110 ucted, which measured T-wave timing using an intracardiac electrogram during a ventricular pacing tra

111 asibility of using real-time, high-fidelity, intracardiac electrogram monitoring from a permanently i

112 nvestigation using real-time, high-fidelity, intracardiac electrogram monitoring from a permanently I

113 MyBP-C(+/+) mice with endocardial pacing and intracardiac electrogram recording.

114 g event was TdP (on electrocardiogram) or an intracardiac electrogram showing pause-dependent PVT.

115 Analysis of stored intracardiac electrograms (EGMs) alerts the physician to

116 electrophysiology studies with recording of intracardiac electrograms and atrial and ventricular pac

117 The clustering of intracardiac electrograms exhibiting spatiotemporal disp

118 We prospectively analyzed intracardiac electrograms in 125 explanted ICDs.

119 localization was confirmed via recording of intracardiac electrograms in both patients.

120 g these is the ability to store counters and intracardiac electrograms of individual atrial high-rate

121 The use of intracardiac electrograms to guide atrial fibrillation (

122 Real-time intracardiac electrograms were recorded during MRI.

123 Intracardiac electrograms, surface electrocardiograms, f

124 ed shocks from ICDs with stored, retrievable intracardiac electrograms.

125 iate ICD therapies were adjudicated based on intracardiac electrograms.

126 Both groups of transgenic mice underwent intracardiac electrophysiologic, electrocardiographic (E

127 Electrocardiography and intracardiac electrophysiological studies revealed first

128 ECG recordings and intracardiac electrophysiology studies demonstrated the

129 Intracardiac electrophysiology studies with programmed s

130 cardiography, intracardiac echocardiography, intracardiac endoscopy, and electroanatomic mapping syst

131 t hypertrophy is minimal and that persistent intracardiac expression of TNF-alpha may contribute to t

132 art failure, lower body mass index, elevated intracardiac filling pressures, lower cardiac index, ane

133 a ratio may not be as reliable in predicting intracardiac filling pressures, particularly in those wi

134 rly with pulmonary hypertension and elevated intracardiac filling pressures.

135 cardiac resynchronization therapy underwent intracardiac flow analysis and AVD optimization.

136 e performed quantitative in vivo analyses of intracardiac flow forces in zebrafish embryos.

137 itive predictive value (PPV) of an echogenic intracardiac focus in this high-risk population was 9.8%

138 lexus cyst, thickened nuchal fold, echogenic intracardiac focus, echogenic bowel, renal pyelectasis,

139 pen (FO) or closed (FC) at end of operation, intracardiac Fontan (IF) or extracardiac Fontan (EF), da

140 thway in patients with a lateral tunnel (LT) intracardiac Fontan connection and outcomes of percutane

141 Na(V)1.8 labeling in dorsal root ganglia and intracardiac ganglia and only modest Na(V)1.8 expression

142 1.8 staining in isolated neurons from murine intracardiac ganglia but no Na(V)1.8 expression in isola

143 t the majority of the CARTp-IR fibers in the intracardiac ganglia were derived from sources extrinsic

144 ptide (VIP) have been found within mammalian intracardiac ganglia, but the cellular effects of these

145 heart diseases argues for the importance of intracardiac haemodynamics as a key epigenetic factor in

146 in 4, extreme vessel tortuosity in 1 and an intracardiac hemangioma in 1.

147 Because cardiac contraction and intracardiac hemodynamic forces can also influence cardi

148 oppler echocardiography accurately estimated intracardiac hemodynamics in these patients supported wi

149 It is well established that intracardiac hemodynamics play a significant role in the

150 is not uncommon and is associated with worse intracardiac hemodynamics, higher B-type natriuretic pep

151 Intracardiac ICD electrograms for subsequent events were

152 The use of intracardiac imaging to guide select cardiac procedures

153 review will propose the features of an ideal intracardiac imaging tool, summarize the intracardiac im

154 eal intracardiac imaging tool, summarize the intracardiac imaging tools that are currently available

155 feasibility of high-resolution phased-array intracardiac imaging.

156 infections were monitored and compared with intracardiac infections.

157 on of the highest DF site were compared with intracardiac information.

158 in on days 1-4, and hMSCs were delivered via intracardiac infusion on days 10 and 17.

159 India ink intracardiac injection analysis displayed a spectrum of

160 metastasis, we developed a mouse model using intracardiac injection and in vivo selection to isolate

161 xenograft model of lung metastasis and in an intracardiac injection model of experimental bone and lu

162 Melanoma metastasis was induced by intracardiac injection of B16F10 cells.

163 ed greater experimental metastases following intracardiac injection of cancer cells.

164 Indeed, intracardiac injection of Gbeta5-targeted shRNA allowed

165 Intracardiac injection of mesenchymal stromal cells tran

166 We performed intracardiac injection of multiple myeloma (MM) cells de

167 Direct intracardiac injection of the DNA enzyme at the time of

168 ed from osseous metastases that formed after intracardiac injection of the MDA-MB-231 cell line in at

169 onance (MR) imaging that therapy with direct intracardiac injection of vascular endothelial growth fa

170 ow, here we used a novel survivable in utero intracardiac injection technique to deliver a vascular t

171 s in inducing myocardial repair after single intracardiac injection using synthetic lipid formulation

172 ravascular administration of donor cells via intracardiac injection was far more efficient and result

173 ected in the brain vasculature 4 hours after intracardiac injection, and a few adherent cells persist

174 t cancer metastasizes to bone are limited to intracardiac injection, which seeds the cancer cells dir

175 ir ability to colonize in the bone following intracardiac injection, while reexpression of phosphoryl

176 2 mimics for at least 12 days after a single intracardiac injection, with minimal dispersion to other

177 ressive osteolytic lesions within 3 weeks of intracardiac injections.

178 at uses ultrasonographic guidance to perform intracardiac injections.

179 ric mean parasite loads (GMPL) comparable to intracardiac inoculation of 10(7)-10(8) parasites, altho

180 hen experimental metastases were induced via intracardiac inoculation, mice bearing CHO/MIP-1alpha tu

181 istration of cells requires intracoronary or intracardiac instrumentation, which is potentially assoc

182 Beating-heart image-guided intracardiac interventions have been evolving rapidly.

183 Pocket, intravascular and intracardiac lead characteristics on x-ray correlate wit

184 new intracardiac visualization and magnetic intracardiac lead positioning tools are examples of just

185 e ischemia induction in all body-surface and intracardiac leads (P<0.0001).

186 of eliminating the need for intravenous and intracardiac leads and their associated risks and shortc

187 For each mapping point, the intracardiac locations were transferred onto an individu

188 Intracardiac mapping was performed to determine the site

189 lts demonstrate that the MGS can be used for intracardiac mapping, pacing, and ablation safely and ef

190 (LVOT) site of origin (SOO) are derived from intracardiac mapping.

191 scopy by creating accurate three-dimensional intracardiac maps.

192 In group 1, ICE identified intracardiac masses (ICM) in all 44 patients; TEE identi

193 of congenital abnormalities, aortic disease, intracardiac masses, and pericardial disease.

194 nclude the detection and characterization of intracardiac masses, thrombi, myocarditis, and sarcoidos

195 Direct intracardiac measurement demonstrated a 30% reduction (P

196 tect subtle F-wave variability, validated by intracardiac measurements.

197 Intracardiac monitoring was performed in 37 patients at

198 A 7F magnetic ablation catheter was used for intracardiac navigation and radiofrequency ablation.

199 We have shown that the intracardiac nervous system in the zebrafish is anatomic

200 In the vertebrate heart the intracardiac nervous system is the final common pathway

201 The intracardiac nervous system represents the final common

202 A small percentage ( approximately 3%) of intracardiac neurons also exhibited TRPC6 immunoreactivi

203 Tachykinins depolarize guinea pig intracardiac neurons by activating nonselective cationic

204 Depolarization of intracardiac neurons by the neuropeptides was dependent

205 ntestinal polypeptide (VIP) is released from intracardiac neurons during vagal stimulation, ischemia,

206 2+]i and neuroexcitability, respectively, in intracardiac neurons of neonatal rats.

207 The mean total number of intracardiac neurons was 713 +/- 78 (SE), nearly half of

208 ting [Ca2+]i, both PACAP and VIP depolarized intracardiac neurons, and PACAP was further shown to aug

209 reduced action potential firing frequency in intracardiac neurons, confirming a functional role for N

210 he functional presence of SCN10A/Na(V)1.8 in intracardiac neurons, indicating a novel role for this n

211 s but significantly reduced I(Na) density in intracardiac neurons.

212 ergistically to enhance neuroexcitability in intracardiac neurons.

213 tic, and sensory-motor nerves, as well as in intracardiac neurons.

214 tly through cardiomyocytes or indirectly via intracardiac neurons.

215 istic standpoint, nitrite treatment restored intracardiac nitrite and increased S-nitrosothiol levels

216 of 5 patients were well without evidence of intracardiac or extracardiac amyloid accumulation, and m

217 wth of metastatic brain tumors introduced by intracardiac or intracranial injection of breast cancer

218 th venous thromboembolism in the presence of intracardiac or pulmonary shunts.

219 hat IDAFL and NIDAFL lie along a spectrum of intracardiac organization.

220 e III collagen synthesis identified cells of intracardiac origin as the main source for collagen turn

221 ms that induce fibrillogenesis of cells with intracardiac origin.

222 al trauma is mainly driven by fibroblasts of intracardiac origin.

223 spleen was determined by real-time PCR after intracardiac perfusion.

224 were returned to their cages for 1 h before intracardiac perfusion.

225 rate the methods, feasibility and utility of intracardiac phased-array vector and Doppler imaging for

226 assessment of the relationship between daily intracardiac pressure and occurrence of ventricular arrh

227 re (HF) management strategy using continuous intracardiac pressure monitoring could decrease HF morbi

228 High-fidelity intracardiac pressure waveforms from 100 consecutive pat

229 ted by an abrupt and substantial increase in intracardiac pressure.

230 Echocardiography easily can measure intracardiac pressures accurately but in a static fashio

231 Among patients with VT/VF, elevated intracardiac pressures are associated with higher VT/VF

232 the Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients with Chronic Heart Fa

233 PVP and intracardiac pressures were obtained by transducing a pe

234 on >/= 50%, increased natriuretic peptide or intracardiac pressures, and reduced exercise capacity.

235 P and RCMP patients had similar elevation in intracardiac pressures.

236 ry, and has been used to perform portions of intracardiac procedures via thoracotomy incisions.

237 Electrocardiographic data, intracardiac recordings, echocardiographic data, and pat

238 The targets comprise myofibroblasts, intracardiac renin-angiotensin axis, matrix metalloprote

239 pericardium (CoA bypass) allows simultaneous intracardiac repair or an alternative approach for the p

240 AT were univentricular physiology, previous intracardiac repair, systemic right ventricle, pulmonary

241 entricular lead placement (n=10) followed by intracardiac right-to-left shunt (n=5).

242 An intracardiac right-to-left shunt (RLS) could allow large

243 factor-kappaB ligand, were injected via the intracardiac route into both wild-type and OPN-/- mice.

244 Symptomatic right-to-left intracardiac shunt may occur in patients with normal int

245 otic heart disease or residual right-to-left intracardiac shunt.

246 the form of thromboembolism, dissection and intracardiac shunting and mass effect over adjacent card

247 tal myocyte proliferation by manipulation of intracardiac shunting at the atrial level.

248 and right-sided valves and occurred without intracardiac shunting in 55% of this surgical series.

249 ume and flow, either globally (left-to-right intracardiac shunting) or from flow and volume diversion

250 No intracardiac shunts were found with echocardiography alo

251 Eight intracardiac shunts were identified, four of which were

252 us cardiopulmonary conditions, patients with intracardiac shunts, and special patient populations inc

253 CHF and in patients with large left-to-right intracardiac shunts.

254 tion and in infants with large left-to-right intracardiac shunts.

255 Intracardiac signal transduction involves: adenosine, br

256 lutter wave morphology and limited recording intracardiac sites proved insufficient to delineate the

257 We report the first clinical studies of intracardiac ST-segment monitoring in ambulatory humans

258 Shifts exceeding 3 SD from a patient's daily intracardiac ST-segment range may be a sensitive/specifi

259 The ECG analyses were compared with intracardiac standard deviations of: 1) atrial electrogr

260 the image quality of native valves and other intracardiac structures.

261 expression, whereas the ganglion is the only intracardiac target of NO, we hypothesize that NO serves

262 Fifth-eight intracardiac thrombi were identified in 42 patients (27%

263 Intracardiac thrombosis occurs frequently in cardiac amy

264 Intracardiac thrombosis was identified in 38 hearts (33%

265 A high frequency of intracardiac thrombosis was present in cardiac amyloidos

266 /transesophageal echocardiographic risks for intracardiac thrombosis, and effect of anticoagulation w

267 The prevalence of intracardiac thrombosis, clinical and transthoracic/tran

268 pendently associated with increased risk for intracardiac thrombosis, whereas anticoagulation was ass

269 dulthood, they eventually succumb to massive intracardiac thrombosis.

270 oidosis, the AL group had significantly more intracardiac thrombus (51% versus 16%, P<0.001) and more

271 R], 91.6; P=0.0041) and clinically diagnosed intracardiac thrombus (HR, 22.7; P=0.0002).

272 ocardial function, which could predispose to intracardiac thrombus formation.

273 valence nor the effect of anticoagulation on intracardiac thrombus has been evaluated antemortem.

274 Although intracardiac thrombus has been reported in anecdotal cas

275 We recently reported a high prevalence of intracardiac thrombus in cardiac amyloid patients at aut

276 AL amyloid had more frequent intracardiac thrombus than the other types (35% versus 1

277 early acute cardioversion (in the absence of intracardiac thrombus) with postcardioversion anticoagul

278 fied into 2 groups: systemic TEC, defined as intracardiac thrombus, ischemic stroke, or systemic arte

279 h-risk patients may allow early detection of intracardiac thrombus.

280 Control hearts had no intracardiac thrombus.

281 Each heart was examined for intracardiac thrombus.

282 A leadless intracardiac transcatheter pacing system has been design

283 enty pigs were chronically instrumented with intracardiac transducers to measure left ventricular pre

284 We tested the hypothesis that intracardiac transplantation of autologous bone marrow-

285 the murine host with cyclophosphamide before intracardiac tumor cell inoculation was found to signifi

286 2 transseptal punctures were performed under intracardiac ultrasound (ICE) guidance, with one of the

287 Both fluoroscopy and intracardiac ultrasound (ICE)-guided balloon and Lasso c

288 Pre-ejection tissue velocity, as measured by intracardiac ultrasound, allows rapid estimation of the

289 function was studied with intravascular and intracardiac ultrasound.

290 pedance signals, utilizing intrathoracic and intracardiac vectors, were measured through ring (r), co

291 Patients with intracardiac vegetations are at high risk for complicati

292 One hundred patients had intracardiac vegetations identified by transesophageal e

293 n patients at a tertiary care center who had intracardiac vegetations identified by transesophageal e

294 Patients with intracardiac vegetations identified on transesophageal e

295 The presence of intracardiac vegetations identifies a subset of patients

296 patients with echocardiographic evidence of intracardiac vegetations, followed by a descriptive and

297 s incorporated into the catheters, measuring intracardiac ventricular electrograms, and integrating t

298 tools, guiding catheters, stenting, and new intracardiac visualization and magnetic intracardiac lea

299 tron-emission tomography (PET) imaging; (2.) intracardiac voltage mapping with visible lesion on ultr

300 expression of human growth hormone following intracardiac, yet not intramuscular, injection.